McClure Health Science High School library media specialist Laura Sly has been selected as the 2024 Gwinnett County Public Schools Library Media Specialist of the Year, the district announced.
Credit: UBC, Michael Smith Laboratories
More Canadians suffer from inflammatory bowel disease (IBD) than anywhere else in the world, yet current treatments often have debilitating side effects and are not always effective.
According to Crohn s and Colitis Canada, 1 in 140 Canadians lives with Crohn s or colitis, the two main forms of IBD. The disease inflames the lining of the gastrointestinal (GI) tract and disrupt the body s ability to digest food, absorb nutrition, and eliminate waste in a healthy matter. This can lead to severe abdominal pain, chronic diarrhea, and life-threatening complications.
GlycoNet researchers from the University of British Columbia, BC Children s Hospital, and Agriculture and Agri-Food Canada, are challenging the status quo as they develop a technology that they termed GlycoCage. This technology is aimed to improve the efficacy of IBD drugs by refining the method of drug delivery to patients.